Pathogenetic Treatment Of Irritable Bowel Syndrome


M.D. Ardatskaya, O.N. Minushkin

Department of Gastroenterology FSBI "Educational and Research Medical Center" of Administrative Department of the President of the Russian Federation, Moscow
The article considers the one of the most common functional bowel disease - irritable bowel syndrome (IBS). The modern definition of IBS is proposed; the basic questions of the pathogenesis of this disease are discussed. In the light of the Rome Consensus III, criteria for the diagnosis of IBS are presented. Based on the mechanisms of development of IBS, the principles of its therapeutic correction are formulated. Particular attention is paid to the place and role of the myotropic spasmolytics in the treatment of IBS; possibility of use of selectively acting calcium channel blocker - pinaverium bromide (Dicetel) is discussed more specifically.

About the Autors


Ardatskaya Maria Dmitrievna - MD, Professor at the Department of Gastroenterology FSBI "Educational and Research Medical Center" of Administrative Department of the President of the Russian Federation.
Minushkin Oleg Nikolayevich- MD, Professor, Head of the Department of Gastroenterology FSBI "Educational and Research Medical Center" of Administrative Department of the President of the Russian Federation.


Similar Articles


Бионика Медиа